Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye
This study, the largest single-center investigation in Türkiye, reveals ADA to be a safe option with functional benefits across diverse indications and age ranges. Notably, ADA minimizes reliance on additional therapies.
Authors
- Çiğdem Altan (ORCID: https://orcid.org/0000-0002-0908-6619)
- Burcu Kemer Atik (ORCID: https://orcid.org/0000-0001-6597-6184)
- Berna Başarır (ORCID: https://orcid.org/0000-0002-4948-948X)
- Berru Yargı Özkoçak (ORCID: https://orcid.org/0000-0002-6801-6178)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul Eye Hospital (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Turkish Journal of Ophthalmology
- Published
- 2025-08-21
- DOI
- https://doi.org/10.4274/tjo.galenos.2025.67513
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00